- MDA5 (Melanoma Differentiation‑Associated protein 5) is a cytosolic pattern‑recognition receptor that detects viral double‑stranded RNA and triggers powerful antiviral signalling. Alongside RIG‑I and LGP2, MDA5 belongs to the RIG‑I‑like receptor (RLR) family, but it specialises in recognising long dsRNA structures produced during replication of picornaviruses, coronaviruses and other RNA viruses. This length‑based recognition makes MDA5 essential for defence against pathogens such as poliovirus, encephalomyocarditis virus (EMCV), measles virus and SARS‑CoV‑2.
- Structurally, MDA5 contains two N‑terminal CARD domains, a central helicase domain and a C‑terminal regulatory domain. Unlike RIG‑I, which binds short 5′‑triphosphorylated RNA fragments, MDA5 forms filamentous assemblies along extended dsRNA molecules. These filaments act as signalling platforms that stabilise CARD exposure and promote downstream activation. The filament formation is ATP‑dependent and highly cooperative, allowing MDA5 to discriminate viral RNA from shorter cellular RNAs that do not support filament growth.
- Once activated, the exposed CARD domains of MDA5 interact with MAVS on the outer mitochondrial membrane. This CARD–CARD interaction triggers MAVS polymerisation into prion‑like filaments that recruit TBK1 and IKKε, leading to phosphorylation of IRF3 and IRF7 and the production of type I interferons. MDA5 also activates NF‑κB, ensuring a broad antiviral transcriptional response. Because MDA5 responds to long dsRNA, it often becomes the dominant sensor during late stages of viral replication when abundant dsRNA intermediates accumulate.
- MDA5 activation is tightly regulated to prevent inappropriate immune responses. The helicase domain maintains autoinhibition until dsRNA binding occurs, and ATP hydrolysis controls filament dynamics. LGP2, the third RLR family member, modulates MDA5 activity by stabilising its filaments and enhancing RNA binding. This regulatory partnership ensures that MDA5 responds only when viral replication produces sufficiently long dsRNA structures.
- Viruses have evolved multiple strategies to evade MDA5 detection. Picornaviruses produce proteases that cleave MAVS, severing the connection between MDA5 and downstream signalling. Coronaviruses generate dsRNA within membrane‑bound replication compartments, shielding it from MDA5. Some viral proteins directly inhibit MDA5 filament formation or block CARD exposure. These antagonistic mechanisms highlight MDA5 as a critical bottleneck in antiviral immunity.
- Beyond classical antiviral defence, MDA5 plays roles in autoimmunity and inflammatory disease. Gain‑of‑function mutations in IFIH1, the gene encoding MDA5, cause excessive interferon production and contribute to disorders such as Aicardi–Goutières syndrome and Singleton–Merten syndrome. Conversely, loss‑of‑function mutations impair antiviral immunity and increase susceptibility to severe viral infections. MDA5 is therefore both a guardian of cellular integrity and a potential driver of pathological inflammation when dysregulated.
- In summary, MDA5 is a specialised sensor of long viral dsRNA that activates MAVS‑dependent interferon signalling. Its filament‑based recognition mechanism distinguishes it from RIG‑I, while its partnership with LGP2 ensures precise regulation. Through its ability to detect replicating RNA viruses and trigger robust antiviral responses, MDA5 remains a central focus in immunology, virology and therapeutic development.
